Diabetic macular oedema quantified with spectral-domain optical coherence tomography - evaluation of boundary line artefacts and the effect on retinal thickness

被引:9
作者
Hodzic-Hadzibegovic, Delila [1 ,2 ]
Sander, Birgit A. [1 ]
Lund-Andersen, Henrik [1 ,2 ,3 ]
机构
[1] Univ Copenhagen, Glostrup Hosp, Dept Ophthalmol, DK-2600 Glostrup, Denmark
[2] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark
[3] Steno Diabet Ctr, DK-2820 Gentofte, Denmark
关键词
anti-vegf treatment; boundary line artefacts; centre-involved; diabetic macular oedema; optical coherence tomography; ranibizumab; SEGMENTATION ERROR; REPRODUCIBILITY; REPEATABILITY; PREVALENCE; STRATUS;
D O I
10.1111/aos.12494
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To characterize frequency, morphological cause and time-dependent change of boundary line artefacts in optical coherence tomography (OCT) examinations of centre-involved diabetic macular oedema (ciDME) patients who underwent ranibizumab treatment with 1-year follow-up and to evaluate the impact of artefacts on retinal thickness. Methods: One hundred and fourteen patients were examined with radial scan protocol by Topcon 3D OCT at baseline, 3 and 12 months. All B scans from all visits were examined for boundary line artefacts (artefacts) and were stratified by morphological element causing artefacts including hard exudates (HE), epiretinal membranes (ERM), optical opacities and serous detachments. Boundary line artefacts were manually corrected and the corrected central subfield thickness (CST) and macular volume were compared with automated values. Data were compared with a repeatability coefficient of 25 mu m. Results: Boundary line artefacts were found in 51.8% of the total 342 OCT examinations and in 25.5% of the total 2052 B scans. Morphological elements that caused artefacts in the total 2052 B scans were HE (10.6%), ERM (10.3%), optical opacities (4.4%), serous detachments (1.7%) and others (1.2%). The number of artefacts due to HE decreased significantly (p = 0.0005), and the number of artefacts due to ERM were unchanged (p = 0.087) during 12 months. In OCT examinations with artefacts caused by HE, manually corrected CST was statistically significant higher than automated value at baseline and 3 months. For ERM, manually corrected CST was statistically significant lower than automated value at baseline and 12 months. Conclusion: Boundary line artefacts in OCT examinations of ciDME patients using Topcon 3D OCT occur in 51.8%. In situation of boundary line artefacts in centre 1-mm area every fourth OCT examination has a change in CST beyond 25 mu m.
引用
收藏
页码:74 / 82
页数:9
相关论文
共 26 条
  • [1] Altman D G., 1991, Practical statistics for medical research, V1st, P179
  • [2] Reliability, repeatability and reproducibility: analysis of measurement errors in continuous variables
    Bartlett, J. W.
    Frost, C.
    [J]. ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2008, 31 (04) : 466 - 475
  • [3] Diabetic Macular Edema: Pathogenesis and Treatment
    Bhagat, Neelakshi
    Grigorian, Ruben A.
    Tutela, Arthur
    Zarbin, Marco A.
    [J]. SURVEY OF OPHTHALMOLOGY, 2009, 54 (01) : 1 - 32
  • [4] Long-term Outcomes of Ranibizumab Therapy for Diabetic Macular Edema: The 36-Month Results from Two Phase III Trials RISE and RIDE
    Brown, David M.
    Quan Dong Nguyen
    Marcus, Dennis M.
    Boyer, David S.
    Patel, Sunil
    Feiner, Leonard
    Schlottmann, Patricio G.
    Rundle, Amy Chen
    Zhang, Jiameng
    Rubio, Roman G.
    Adamis, Anthony P.
    Ehrlich, Jason S.
    Hopkins, J. Jill
    [J]. OPHTHALMOLOGY, 2013, 120 (10) : 2013 - 2022
  • [5] Comparison of the clinical diagnosis of diabetic macular edema with diagnosis by optical coherence tomography
    Browning, DJ
    McOwen, MD
    Bowen, RM
    O'Marah, TL
    [J]. OPHTHALMOLOGY, 2004, 111 (04) : 712 - 715
  • [6] Repeatability of Spectralis OCT Measurements of Macular Thickness and Volume in Diabetic Macular Edema
    Comyn, Oliver
    Heng, Ling Zhi
    Ikeji, Felicia
    Bibi, Kanom
    Hykin, Philip G.
    Bainbridge, James W.
    Patel, Praveen J.
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2012, 53 (12) : 7754 - 7759
  • [7] Current Epidemiology of Diabetic Retinopathy and Diabetic Macular Edema
    Ding, Jie
    Wong, Tien Yin
    [J]. CURRENT DIABETES REPORTS, 2012, 12 (04) : 346 - 354
  • [8] Domalpally A, 2010, OPHTHAL SURG LAS IM, V47, P34
  • [9] QUALITY ISSUES IN INTERPRETATION OF OPTICAL COHERENCE TOMOGRAMS IN MACULAR DISEASES
    Domalpally, Amitha
    Danis, Ronald P.
    Zhang, Baoyan
    Myers, Dawn
    Kruse, Christina N.
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2009, 29 (06): : 775 - 781
  • [10] Intravitreal Ranibizumab for Diabetic Macular Edema with Prompt versus Deferred Laser Treatment Three-Year Randomized Trial Results
    Elman, Michael J.
    Qin, Haijing
    Aiello, Lloyd Paul
    Beck, Roy W.
    Bressler, Neil M.
    Ferris, Frederick L., III
    Glassman, Adam R.
    Maturi, Raj K.
    Melia, Michele
    [J]. OPHTHALMOLOGY, 2012, 119 (11) : 2312 - 2318